Results 161 to 170 of about 563,010 (309)

Integrated de novo gene prediction and peptide assembly of metagenomic sequencing data. [PDF]

open access: yesNAR Genom Bioinform, 2023
Thippabhotla S   +6 more
europepmc   +1 more source

TREX1, a predator for treating MSI‐H tumors?

open access: yesMolecular Oncology, EarlyView.
Immunotherapy benefits many patients; yet, some with MSI‐H tumors remain unresponsive despite their high immunogenicity. Xu et al. reveal that TREX1 enables immune evasion by degrading cytosolic DNA and suppressing cGAS–STING–IFN‐I signaling. TREX1 loss restores DNA sensing, increases CD8+ T and NK cell infiltration, and boosts antitumor immunity ...
Elena Benidovskaya   +2 more
wiley   +1 more source

FragGeneScanRs: faster gene prediction for short reads. [PDF]

open access: yesBMC Bioinformatics, 2022
Van der Jeugt F, Dawyndt P, Mesuere B.
europepmc   +1 more source

LINC01116, a hypoxia‐lncRNA marker of pathological lymphangiogenesis and poor prognosis in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
The LINC01116 long noncoding RNA is induced by hypoxia and associated with poor prognosis and high recurrence rates in two cohorts of lung adenocarcinoma patients. Here, we demonstrate that besides its expression in cancer cells, LINC01116 is markedly expressed in lymphatic endothelial cells of the tumor stroma in which it participates in hypoxia ...
Marine Gautier‐Isola   +12 more
wiley   +1 more source

FAM family gene prediction model reveals heterogeneity, stemness and immune microenvironment of UCEC. [PDF]

open access: yesFront Mol Biosci, 2023
Chi H   +14 more
europepmc   +1 more source

Prediction and identification of immune genes related to the prognosis of patients with colon adenocarcinoma and its mechanisms [PDF]

open access: green, 2020
Sihan Chen   +8 more
openalex   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

Home - About - Disclaimer - Privacy